Provided by Tiger Trade Technology Pte. Ltd.

RxSIGHT, INC.

6.25
+0.16002.63%
Post-market: 6.250.00000.00%19:36 EDT
Volume:1.54M
Turnover:9.49M
Market Cap:258.73M
PE:-5.49
High:6.31
Open:6.10
Low:6.00
Close:6.09
52wk High:13.22
52wk Low:4.48
Shares:41.40M
Float Shares:36.26M
Volume Ratio:2.46
T/O Rate:4.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1385
EPS(LYR):-0.9533
ROE:-17.35%
ROA:-10.41%
PB:0.98
PE(LYR):-6.56

Loading ...

Rxsight - Guides 2026 Revenue of $140-$160 Mln

THOMSON REUTERS
·
Jul 07

Rxsight Q2 Revenue USD 27 Million VS. Ibes Estimate USD 32.1 Million

THOMSON REUTERS
·
Jul 07

Rxsight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

THOMSON REUTERS
·
Jul 07

Alcon AG - Rxsight to Receive $60 Mln Upfront Payment Under Agreement

THOMSON REUTERS
·
Jul 07

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

GlobeNewswire
·
Jul 07

RxSight Stockholders Back Leadership at 2026 Annual Meeting

TIPRANKS
·
Jun 17

RxSight stockholders approve advisory executive pay plan at annual meeting

Reuters
·
Jun 17

RxSight Securities Lawsuit Advances After Court Denies Dismissal Bid

TIPRANKS
·
May 30

Analysts Conflicted on These Healthcare Names: RxSight (RXST), Liquidia Technologies (LQDA) and Krystal Biotech (KRYS)

TIPRANKS
·
May 14

RxSight Earnings Call Balances Growth With Headwinds

TIPRANKS
·
May 12

Analysts Have Conflicting Sentiments on These Healthcare Companies: Voyager Therapeutics (VYGR), Alpha Teknova (TKNO) and RxSight (RXST)

TIPRANKS
·
May 09

RxSight price target lowered to $11 from $13 at Needham

TIPRANKS
·
May 07

Needham Cuts Price Target on RxSight to $11 From $13, Keeps Buy Rating

MT Newswires Live
·
May 07

RxSight Is Maintained at Buy by Needham

Dow Jones
·
May 07

Rxsight Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

RxSight Q1 revenue beats estimates

Reuters
·
May 07

RxSight Q1 net loss widens to $(15.9) million; sales fall 18.5% to $30.9 million

Reuters
·
May 07

RxSight Q1 Adj. EPS $(0.19) Beats $(0.28) Estimate, Sales $30.893M Beat $29.744M Estimate

Benzinga Earnings
·
May 07

BRIEF-Rxsight Q1 Revenue USD 30.9 Million Vs. IBES Estimate USD 29.7 Million

Reuters
·
May 07

Rxsight Q1 Adjusted EPS USD -0.19 VS. Ibes Estimate USD -0.28

THOMSON REUTERS
·
May 07